|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/12 | (2006.01) |
| C12N 9/1205 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C12Q2600/106 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| C12Q2600/136 | (2013.01) | ||
| A61P 35/04 | (2006.01) | ||
| C12Q2600/156 | (2013.01) | ||
| C12Q 1/6886 | (2018.01) | ||
| C12Y 207/12002 | (2013.01) | ||
| C12Q 1/6886 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/04 | (2018.01) |
| (11) | Number of the document | 3889254 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21158530.2 |
| Date of filing the European patent application | 2011-06-09 | |
| (97) | Date of publication of the European application | 2021-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2024-08-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 35295910 P | 2010-06-09 | US |
| (72) |
GARRAWAY, Levi A , US
EMERY, Caroline , US
WAGLE, Nikhil , US
|
| (73) |
Dana-Farber Cancer Institute, Inc. ,
450 Brookline Avenue, Boston, MA 02215,
US
|
| (54) | A MEK1 MUTATION CONFERRING RESISTANCE TO RAF AND MEK INHIBITORS |
| A MEK1 MUTATION CONFERRING RESISTANCE TO RAF AND MEK INHIBITORS |